Funder: European Commission
Due Dates: April 13, 2027 (first-stage) | September 22, 2027 (second-stage)
Funding Amounts: ~€10,000,000 per project; total call budget €39,300,000; ~4 grants expected
Summary: Funds early-stage clinical trials and research to advance innovative interventions for neurodegenerative diseases, emphasizing multidisciplinary approaches, technology, and stakeholder engagement.